Home | Contact | HelpDesk |
Search
James Hogg Research Laboratories

Jiri Frohlich, MD, FRCPC

Academic Director, St. Paul's Hospital Healthy Heart Program
Director, St. Paul's Hospital Lipid Clinic
Professor, Pathology and Laboratory Medicine, University of British Columbia

St. Paul's Hospital
rm 180 - 1081 Burrard Street
Vancouver, B.C, V6Z 1Y6

Phone: (604) 806-8612
E-mail: email Jiri Frohlich

Enter the two words below to reveal the email address 

Dr. Frohlich's specialty is medical biochemistry, which is a subspecialty of Pathology and Laboratory Medicine. Over the last 25 years he has further sub-specialized into laboratory and clinical aspects of lipoprotein metabolism and atherosclerosis. Currently, he is the Director of the Lipid Clinic and Academic Director of the Healthy Heart Program at St. Paul's Hospital.

Dr. Frohlich's current areas of active research are dyslipidemias, atherosclerosis, phytosterols in medicine, genetic determinants of response to inflammation and atherosclerosis, and HDL metabolism as well as a clinical trial of new lipid lowering medications.

 

 

 

Education / Training:

M.D. from Karlova University, Prague; Dr. Frohlich's specialty is medical biochemistry, which is a subspecialty of Pathology and Laboratory Medicine. Over the last 25 years he has further sub-specialized into laboratory and clinical aspects of lipoprotein metabolism and atherosclerosis. Currently, he is the Director of the Lipid Clinic and Academic Director of the Healthy Heart Program at St. Paul's Hospital.

Research Interests:

Dr. Frohlich's current areas of active research are dyslipidemias, atherosclerosis, phytosterols in medicine, genetic determinants of response to inflammation and atherosclerosis, and HDL metabolism as well as clinical trial of new lipid lowering medications

Recent Publications [+]

Publications in Pubmed

Chan SY, Mancini GB, Ignaszewski A, Frohlich J. Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study. BMC Clin Pharmacol. 2008 Oct 28;8:10.

Holmes DT, Frohlich JJ. The Canadian lipid guidelines are difficult to model quantitatively. Can J Cardiol. 2008 Aug;24(8):621.

Taraboanta C, Wu E, Lear S, DiPalma S, Hill J, Mancini GB, Frohlich J. Subclinical atherosclerosis in subjects with family history of premature coronary artery disease. Am Heart J. 2008 Jun;155(6):1020-1026.e1.

Al Riyami NB, Frohlich J. Extreme hypertriglyceridemia following intravenous heparin infusion. Clin Biochem. 2008 Jul;41(10-11):907-9.

Wiesinger HA, Shah J, White A, Yoshida EM, Frohlich J, Sirrs S, Gill S, Byrne MF. Liver biochemistry abnormalities in a quaternary care lipid clinic database. Ann Hepatol. 2008 Jan-Mar;7(1):63-6.

Holmes DT, Frohlich J, Buhr KA. The concept of precision extended to the atherogenic index of plasma. Clin Biochem. 2008 May;41(7-8):631-5.

 

HLI